Surgical treatment for invasive lobular carcinoma of the breast

The Breast - Tập 12 - Trang 23-35 - 2003
M Hussien1, T.F Lioe1, J Finnegan1, R.A.J Spence1
1Breast Surgery Unit, Belfast City Hospital, Lisburn Road, Belfast BT9 7AB, UK

Tài liệu tham khảo

1. Pierson K K, Wilkinson E J. Malignant neoplasia of the breast: infiltrating carcinomas. In: Bland K I and Copeland E M, eds. The Breast. Philadelphia, PA: WB Saunders Company, 1991; 193–209.

2. Miller N, McPherson K, Jones L. Histopathology of breast cancer in younger women in relation to use of oral contraceptives. J Clin Path 1989; 42: 387–390.

3. Rosen P P. The pathology of invasive breast carcinoma. In: Harris JR, Hellman S, Henderson J C and Kinne D W, eds. Breast Diseases, 2nd Edition Philadelphia, PA: JB Lippincott, 1991; 245–296.

4. NIH Consensus Conference. Treatment of early stage breast cancer. JAMA 1991; 265: 391–395.

5. Fisher B, Redmond C, Poisson R. Eight year results of a randomised clinical trial comparing total mastectomy and lumpectomy with or without irradication in the treatment of breast cancer. N Eng J Med 1989; 320: 822–828.

6. Kaplan E L, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457–481.

7. Veronesi U, Saccozzi R, Delvecchio M, Banti A, Clemente C, De Lena M. Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast. N Eng J Med 1981; 305: 6 –11.

8. Van Dangen J A, Bartelink H, Fentiman J S, Lerut T, Mignolet F, Olthuis G. Randomised clinical trial to assess the value of breast conserving therapy in stage 1 and stage 2 breast cancer. EORTC 10801 trial. J Natl Cancer Inst Monogr 1992; 11: 15–18.

9. Fowble B, Solin L J, Schultz D J. Conservative surgery and radiation therapy for early breast cancer. In: Fowble B, Goodman R L, Glick J H and Rosato E F, eds. Breast Cancer Treatment: A Comprehensive Guide to Management. St Louis: Mosby-Year Book, 1991; 105–150.

10. Fourguet A, Campana F, Zafrani B, Mosseri V, Vielh P, Durand JC. Prognostic factors of breast recurrence in conservative management of early breast cancer: a 25 year follow up. Int J Radiat Oncol Biol Phys 1989; 17: 719–725.

11. Fisher ER, Gregorio R, Redmond C, Vellios F, Sommers SC, Fisher B. Pathologic findings from the national surgical adjuvant breast project (protocol 4): observations concerning the multicentricity of mammary cancer. Cancer 1975; 35: 247–254.

12. Lesser M L, Rosen P P, Kinne D W. Multicentricity and bilaterality in invasive breast carcinoma. Surgery 1982; 91: 234–240.

13. Holland P A, Shah A, Howell A, Baildam A D, Bundred N J. Lobular carcinoma of the breast can be managed by breast conserving therapy. Br J Surg 1995; 82: 1364–1366.

14. Moreno-Elola A, Aguilar A, Roman J M, Hernandez A, Martin M, Rubio E D, Furio V, Fernandez C, De La Fuente P, San Roman J M, Escudero M. Prognostic factors in invasive lobular carcinoma of the breast: a multivariate analysis. a multicentre study after seventeen years of follow up. Ann Chirurg Gynaecol 1999; 88: 252–258.

15. Sastre-Garau X, Jouve M, Asselain B, Vincent-Salomon A, Beuzeboc P, Dorval T, Duranol JC, Fourquet A, Pouillart P. Infiltrating lobular carcinoma of the breast. Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns. Cancer 1996; 7: 113–120.

16. Di Costanzo D, Rosen P P, Gareen I, Franklin S, Lesser M. Prognosis in infiltrating lobular carcinoma. An analysis of “classical” and variant tumours. Am J Surg Pathol 1990; 14: 12–23.

17. Fisher E R, Sass R, Fisher B. Pathologic findings from the National Surgical Adjuvant Breast Project (protocol b): relation of local breast recurrence to multicentericity. Cancer 1986; 57: 1717–1724.

18. Recht A, Silver B, Schnitt S, Connolly J, Hellman S, Harris JR. Breast relapse following primary radiation therapy for early stage breast cancer: I Classification, frequency and salvage. Int J Radiat Oncol Biol Phys 1985; 11: 1271–1276.

19. Schnitt S J, Connolly J L, Recht A, Silver B, Harris J R. Influence of infiltrating lobular histology on local tumour control in breast cancer patients treated with conservative surgery and radiotherapy. Cancer 1989; 64: 448–454.

20. Horn P L, Thompson W D. Risk of contra-lateral breast cancer: Assocation with histologic, clinical and therapeutic factors. Cancer 1988; 62: 412–424.

21. Warneke J, Berger R, Johnson C, Stea D, Villar H . Lumpectomy and radiation treatment for invasive lobular carcinoma of the breast. Am J Surg 1996; 172: 496–500.

22. Kurtz J M, Jacquemier J, Torhorst J, Spitalier J M, Amalric R, Hünig R, Walther E, Harder F, Almendral A, Brandone H, Ayme Y, Roth J. Conservation therapy for breast cancers other than infiltrating duct carcinoma. Cancer 1989; 63: 1630–1635.

23. Du Toit R S, Locker A P, Ellis I O, Elston C W, Nicholson R L, Robertson J F R, Blamey R W. An evaluation of differences in prognosis, recurrence patterns and receptor status between invasive lobular and other invasive carcinomas of the breast. Eur J Surg Oncol 1991; 17: 251–257.

24. Baker RR. Unusuallesions, their mangement. Surg Clin North Am 1990; 70: 963–75.

25. Dixon J M, Anderson T J, Page D L, Lee D, Duffy S W, Stewart H J. Infiltrating lobular carcinoma of the breast: an evaluation of the incidence and consequence of bilateral disease. Br J Surg 1983; 70: 513–516.

26. Fisher E R, Fisher B. Lobular carcinoma of the breast: an overview. Am Surg 1977; 185: 377–385.

27. Silverstein M J, Lewinsky B S, Waisman J R, Glerson E D, Colburn W J, Senofsky G M, Gamagami P. Infiltrating lobular carcinoma: Is it different from infiltrating duct carcinoma? Cancer 1994; 73: 1673–1677.

28. Weiss M L, Fowble B L, Solin L J, Tien Yeh I, Schultz D J. Outcome of conservative therapy for invasive breast cancer by histologic subtype. Int J Radiat Oncol Biol Phys 1992; 23: 941–947.

29. Wicks K, Fisher CJ, Sentiman IS. Breast cancer history and age. J Pathol 1992; 167: 139A.

30. Yeatman T J, Cantor A B, Smith T J, Smith S K, Reintgen D S, Miller M S, KU NNK, Backey PA, Cox CE. Tumour biology of infiltrating lobular carcinoma. Implications for management. Am Surg 1995; 222: 549–561.

31. Mate T P, Carter D, Fischer D B, Hartman P V, McKhann C, Merino M, Prosnitz L R, Weissberg J B. A clinical and histopathologic analysis of the results of conservation surgery and radiation therapy in stage I and II breast cancer. Cancer 1986; 58: 1995–2002.

32. Adam H O, Malker B, Meirik O. Age as a prognostic factor in breast cancer. Cancer 1985; 56: 898–902.

33. Frykberg E R, Santiago F, Betsill W L, O’Brien P H. Lobular carcinoma in situ of the breast. Surg Gynecol Obstet 1987; 164: 285–301.

34. Anderson J A. Lobular carcinoma insitu: a long term follow up of 52 cases. Acta Pathol Microbiol Scand 1974; 82: 1298–1303.

35. Smith D B, Howell A, Wagstaff J. Infiltrating lobular carcinoma of the breast: response to endocrine therapy and survival. Eur J Clin Oncol 1987; 23: 979–982.

36. Davis R P, Nora P F, Kooy R G, Hines J R. Experience with lobular carcinoma of the breast. Emphasis on recent aspects of management. Arch Surg 1979; 114: 485–488.

37. Fowble B R, Gray R, Gilchrist K, Goodman R L, Taylor S, Tormey D C. Identification of a subgroup of patients with breast cancer and histologically positive nodes receiving adjuvant chemotherapy who may benefit from postoperative radiotherapy. J Clin Oncol 1988; 6: 1107–1117.

38. Overgaard M, Hansen P S, Overgaard J, Rose C, Andersson M, Bach F, Kjaer M, Gadeberg C C, Mouridsen H T, Jensen M B, Zedeler K. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. N Eng J Med 1997; 337: 949–955.

39. Goldhirsch A, Glick J H, Gelber R D, Senn H J. Meeting Highlights: International Consensus panel on the treatment of primary breast cancer. J Natl Cancer Inst 1998; 90: 1601–1608.

40. Ashikari R, Huvos A G, Urban J A, Robbins G F. Infiltrating lobular carcinoma of the breast. Cancer 1973; 31: 110–116.

41. Smith D B. Infiltrating lobular carcinoma of the breast: response to endocrine therapy and survival. Eur J Cancer Clin Oncol 1987; 23: 979–982.

42. Rosen P P, Groshen S, Saigo P E, Kinne D W, Hellman S. Pathological prognostic factors in stage I (T1, N0, M0) and stage II (T1, N1, M0) breast carcinoma: a study of 644 patients with median follow up of 18 years. J Clin Oncol 1989; 7: 1239–1251.

43. Calle R, Vilcoq R, Zofrani B, Viehl P, Forguet A. Local control and survival of breast cancer treated by limited surgery followed by irradiation. Int J Radiat Oncol Biol Phys 1986; 12: 873–878.

44. Clark R M, Wilkinson R H, Mahoney L J, Reid J G, MacDonald W D. Breast cancer, a 21 year experience with conservative surgery and radiation. Int J Radiat Oncol Biol Phys 1982; 8: 967–975.

45. Sariego J, Byrd M, Kerstein M, Matsumoto T. Factors influencing survival in infiltrating lobular carcinoma of the breast. Am Surg 1993; 59: 405–409.

46. White J R, Gustafson G S, Wimbish K, Ingold J A, Lucas R J, Levine A J, Matter R A, Martinez A, Vicini F A. Conservative surgery and radiation therapy for infiltrating lobular carcinoma of the breast. Cancer 1994; 74: 640–647.

47. Poen J C, Tran L, Juillard G, Selch M T, Giuliano A, Silverstein M, Fingerhut A, Lewinsky B, Parker G. Conservation therapy for invasive lobular carcinoma of the breast. Cancer 1992; 69: 2789–2795.

48. Tinnemans J G M, Wobbes T, Vandersluis R F, Lubbers E J C, de Boer HHM. Multicentericity in nonpalpable breast carcinoma and its implications for treatment. Am J Surg 1986; 151: 334 –338.

49. Gump F E, Shikora S, Habif D V. The extent and distribution of cancer in breasts with palpable primary tumours. Am Surg 1986; 204: 384–390.

50. Leis H P Jun. Selective elective prophylactic contralateral mastectomy. Cancer 1971; 28: 956–961.

51. Donegan W L, Perez-Mesa C M. Lobular carcinoma—an indication for elective biopsy of the second breast. Am Surg 1972; 176: 178–187.

52. Hillerea D J, Anderson I T, Lindholm K. Invasive lobular carcinoma: mammographic findings in a 10 year experience. Radiology 1991; 178: 149–154.

53. Van Bogaert L J, Mazy G. Reliability of the cyto-radioclinical triplet in breast pathology diagnosis. Acta Cytol 1977; 21: 60–62.

54. Thomas J, Fiszharris B, Redding W. Clinical examination, xero mammography and fine needle aspiration cytology in a diagnosis of breast tumours. Br Med J 1978; 2: 1139–1142.

55. Hermansen L, Skovgaard-poulsen H, Jensen J. Diagnostic reliability of combined physical examination, mammography and fine needle puncture (‘triple test’) in breast tumours. A prospective study. Cancer 1987; 60: 1866–1871.

56. Winchester D P, Cox J D. Standards for diagnosis and management of invasive breast cancer. CA Cancer J Clin 1998; 48: 83–107.

Thông tin
Thông tin xuất bản

The Breast

Tập 12

23-35

Thông tin tác giả